← back to search

Andrew Dunford

Broad Institute ·
Area of research
Hematology · Cancer Research
Research interest
Research interests include Multiple Myeloma Research and Treatments, Cancer Genomics and Diagnostics, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Acute Myeloid Leukemia Research.
h-index
38
citations
20,063
works
168
NIH funding
primary concept
Biology
email

Recent publications

Genomic landscape of multiple myeloma and its precursor conditions
Nature Genetics 2025cited by 27position: middledoi
DLB<i>class</i>: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphoma
Blood 2024cited by 30position: middledoi
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature Genetics 2023cited by 5position: middledoi
Author Correction: Patterns of somatic structural variation in human cancer genomes
Nature 2023cited by 4position: middledoi
Molecular map of chronic lymphocytic leukemia and its impact on outcome
Nature Genetics 2022cited by 145position: middledoi
Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
Nature Communications 2022cited by 0position: middledoi
Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
Nature Communications 2022cited by 0position: middledoi
<i>ZBTB33</i> Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing
Blood Cancer Discovery 2021cited by 42position: middledoi
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature Genetics 2020cited by 765position: middledoi
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
Nature Genetics 2020cited by 472position: middledoi
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
Nature Genetics 2020cited by 305position: middledoi
Genomic footprints of activated telomere maintenance mechanisms in cancer
Nature Communications 2020cited by 138position: middledoi
High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
Nature Communications 2020cited by 75position: middledoi
Publisher Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature Genetics 2020cited by 13position: middledoi
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion
Blood Advances 2019cited by 162position: middledoi
Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Blood 2019cited by 104position: middledoi
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine 2018cited by 1,952position: middledoi
Author Correction: Molecular subtypes of diffuse large B celllymphoma are associated with distinct pathogenic mechanisms and outcomes
Nature Medicine 2018cited by 32position: middledoi
Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers
Genetics in Medicine 2017cited by 37position: middledoi
Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias
Nature Genetics 2016cited by 474position: firstdoi
Targetable genetic features of primary testicular and primary central nervous system lymphomas
Blood 2015cited by 597position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Gad Getz · Broad Institute4 papers (2016–2024)Chip Stewart · Broad Institute3 papers (2019–2024)Robert Redd · Massachusetts General Hospital3 papers (2019–2024)Margaret A. Shipp · Harvard University3 papers (2019–2024)Bjoern Chapuy · Humboldt-Universität zu Berlin3 papers (2019–2024)Kirsty Wienand · Broad Institute3 papers (2019–2024)Atanas Kamburov · Columbus McKinnon (United States)2 papers (2019–2019)Matthew D. Ducar · Dana-Farber Cancer Institute2 papers (2019–2019)Aaron R. Thorner · Dana-Farber Cancer Institute2 papers (2019–2019)Scott J. Rodig · Massachusetts Institute of Technology2 papers (2019–2019)Jaegil Kim · GlaxoSmithKline (United States)2 papers (2019–2019) · 1 papers (2019–2019)Jonathan R. Fromm · The University of Western Australia1 papers (2019–2019) · 1 papers (2024–2024)Joji Shimono · Okayama University Hospital1 papers (2024–2024)David M. Weinstock · Harvard University1 papers (2016–2016) · 1 papers (2019–2019)Kamil Bojarczuk · Universitätsmedizin Göttingen1 papers (2019–2019) · 1 papers (2019–2019) · 1 papers (2019–2019)